Sunday 18 October 2026
Export ADGM’s income statement to Excel — free account
Adagio Medical Holdings, Inc.
ADGM Healthcare Medical Devices
Adagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023. In the quarter to June 2026, revenue fell 33.5%, EPS fell 15.4%, free cash flow fell 12.9% and total debt rose 46.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.10
0.00
0.00%
Follow ADGM
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | 9.73 | 9.70 | 10.10 | 0.95 | 0.63 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | 12.38 | 10.10 | 10.95 | 11.57 | 2.87 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 71 | 41 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | 0.00 | 0.01 | 0.00 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 0 | 1 | — | ||||
| Gross margin, % | — | — | — | — | — | — | — | (335.33) | (451.16) | 0.00 | |||||
| EBT | — | — | — | 0 | 0 | (7) | 1 | (37) | (75) | (25) | |||||
| EBT margin, % | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | (12,196.67) | (12,465.28) | 0.00 | |||||
| Net income | — | 0 | — | 0 | 0 | (7) | 1 | (37) | (75) | (25) | |||||
| Depreciation | — | — | — | — | — | — | — | 1 | 32 | 1 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.39 | 0.04 | 0.00 | ||||
| Earnings | — | — | — | — | 0.00 | (1.81) | 0.29 | (48.14) | (4.81) | (1.51) | |||||
| Cash flow | — | — | — | 0.00 | 0.00 | (0.29) | (0.13) | (33.75) | (1.89) | (1.15) | |||||
| Capex | — | — | — | — | 0.00 | 0.00 | 0.00 | (0.45) | (0.11) | (0.02) | |||||
| Free cash flow | — | — | — | 0.00 | 0.00 | (0.29) | (0.13) | (34.20) | (2.00) | (1.17) | |||||
| Book value | — | — | — | 0.00 | 0.00 | (2.84) | (2.31) | (53.36) | 1.28 | 0.75 | |||||
| Shares, m | — | — | — | — | 19 | 4 | 4 | 1 | 16 | 17 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||
| P/S | — | — | — | — | — | — | — | 0.00 | 27.19 | — | |||||
| P/B | — | — | — | — | — | — | — | 0.00 | 0.82 | — | |||||
| EV/Sales | — | — | — | — | — | — | — | 0.00 | 19.70 | — | |||||
| EV/FCF | — | — | — | — | — | — | — | (0.27) | (0.38) | — | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | 0 | 0 | (1) | 0 | (26) | (29) | (19) | ||||
| Capex | — | — | — | — | — | — | — | 0 | (2) | 0 | |||||
| Free cash flow | — | — | — | 0 | 0 | (1) | 0 | (26) | (31) | (19) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | 0 | 0 | (5) | (6) | (42) | 18 | 12 | ||||
| Total debt | — | — | — | — | — | — | 0 | 0 | 16 | 21 | |||||
| Net debt | — | — | — | — | — | (1) | 0 | (1) | (5) | 4 | |||||
| Shareholders’ equity | — | — | — | 0 | 0 | (10) | (9) | (41) | 20 | 12 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | (63.53) | (31.76) | (8.72) | 0.71 | (46.14) | (271.53) | (54.71) | ||||
| ROIC | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (341.51) | (83.74) | |||||
| ROE | — | — | — | 100.00 | 100.00 | 127.31 | (11.27) | 52.02 | 133.87 | (155.25) | |||||
Negative figures in brackets.
Fiscal years to Dec 2024 · latest quarter Dec 2024
Charts ten years each
Adagio Medical Holdings, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| ICCM IceCure Medical Ltd. | $3.6M | — (loss-making) | — (loss-making) | −0.69% (below 0%: shrinking) | n/m | +3.88% (above 0%: growing) | 32.38% | (466.19%) | Compare |
| BJDX Bluejay Diagnostics, Inc. | $3.5M | 0.9× | — (loss-making) | — | n/m | +20.05% (above 0%: growing) | 0.00% | 0.00% | Compare |
| ADGM Adagio Medical Holdings, Inc. | $2.8M | — (loss-making) | — | −33.50% (below 0%: shrinking) | n/m | −12.86% (below 0%: shrinking) | 0.00% | 0.00% | |
| IVF INVO Fertility, Inc | $2.8M | 0.0× | — (loss-making) | +16.73% (above 0%: growing) | n/m | +35.07% (above 0%: growing) | 35.06% | (59.28%) | Compare |
| NXL Nexalin Technology, Inc. | $2.6M | — (loss-making) | — (loss-making) | −82.72% (below 0%: shrinking) | n/m | −97.23% (below 0%: shrinking) | 72.95% | (18,420.49%) | Compare |
| BIOLQ Biolase, Inc. | $2.3M | — (loss-making) | — (loss-making) | −0.65% (below 0%: shrinking) | n/m | −60.22% (below 0%: shrinking) | 40.39% | (6.41%) | Compare |
| XAIR Beyond Air, Inc. | $2.2M | — (loss-making) | — (loss-making) | +0.45% (above 0%: growing) | n/m | −9.10% (below 0%: shrinking) | 12.73% | (373.98%) | Compare |
| NUVOQ Holdco Nuvo Group D.G Ltd. | $2.1M | — (loss-making) | — | — | n/m | −1.05% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| VJET Flyte Aviation, Inc. | $2.1M | — (loss-making) | — (loss-making) | +380.66% (above 0%: growing) | n/m | −26.70% (below 0%: shrinking) | 9.62% | (388.13%) | Compare |
| Median of peers | $2.5M | — | — | −0.10% | — | −5.07% | 22.55% | (216.63%) |
Adagio Medical Holdings, Inc. (ADGM) key facts
- Strength: Adagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023.
- Adagio Medical Holdings, Inc. (ADGM) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, ADGM traded at $0.10, a market capitalization of $2.8 million.
- Return on equity was −155.3% and debt-to-equity -59.85.
- Its Altman Z-score is −6.98 (distress zone) for fiscal 2024.